A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adenoassociated virus vectors

Gene Therapy

Volumn 3, Issue 12, 1996, Pages 1124-1132

  Reed Clark, K ^a   Voulgaropoulou, F ^a,b   Johnson, P R ^a,b,c  

^a Children's Hosp Research Foundation   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

AAV; rAAV; Stable cell lines; Titration

Indexed keywords

HELICASE; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ARTICLE; CELL LINE; CONTROLLED STUDY; GENE INDUCTION; GENE TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE; VIRION; VIRUS CAPSID; VIRUS GENE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS REPLICATION;

ADENOVIRIDAE; CAPSID; CELL LINE; DEPENDOVIRUS; DNA-BINDING PROTEINS; GENES, VIRAL; GENETIC VECTORS; HELA CELLS; HELPER VIRUSES; HUMANS; RNA, MESSENGER; TITRIMETRY; VIRAL PROTEINS; VIRUS ASSEMBLY;

EID: 0030458783     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Flotte TR. Prospects for virus-based gene therapy for cystic fibrosis. J Bioenerg Biomembr 1993; 25: 37-42.
2. Kotin RM. Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum Gene Ther 1994; 5: 793-801.
3. Muzyczka N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol 1992; 158: 97-129.
4. Atchison RW, Casto BC, Hammon wM. Adenovirus-associated defective virus particles. Science 1965; 149: 754-756.
5. Buller RM, Janik JE, Sebring ED, Rose JA. Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J Virol 1981; 40: 241-247.
6. Hoggan MD, Blacklow NR, Rowe WP. Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc Natl Acad Sci USA 1966; 55- 1457-1471.
7. McPherson RA, Rosenthal LJ, Rose JA. Human cytomegalovirus completely helps adeno-associated virus replication. Virology 1985; 147:217-222.
8. Blacklow NR et al. Epidemiology of adenovirus-associated virus infection in a nursery population. Am J Epidemiol 1968; 8: 368-378
9. Blacklow NR et al. A seroepidemiologic study of adenovirus-associated virus infections in infants and children. Am J Epidemiol 1971; 94: 359-366.
10. Kotin RM et al. Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 1990; 87: 2211-2215.
11. Samulski RJ et al. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J 1991; 10: 3941-3950 and published erratum EMBO J 1992; 11: 1228.
12. Weitzman MD, Kyostio SR, Kotin RM, Owens RA. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc Natl Acad Sci USA 1994; 91: 5808-5812.
13. Giraud C, Winocour E, Berns KI. Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. J Virol 1995; 69: 6917-6924.
14. McLaughlin SK, Collis P, Hermonat PL, Muzyczka N. Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol 1988, 62: 1963-1973.
15. Bohenzky RA, LeFebvre RB, Berns KI. Sequence and symmetry requirements within the internal palindromic sequences of the adeno-associated virus terminal repeat. Virology 1988; 166: 316-327.
16. Samulski RJ, Chang LS, Shenk T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 1989; 63: 3822-3828.
17. Chiorini JA et al. High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum Gene Ther 1995; 6: 1531-1542.
18. Clark KR, Voulgaropoulou F, Fraley DM, Johnson PR. Cell lines for the production of recombinant adeno-associated virus. Hum Gene Ther 1995; 6: 1329-1341.
19. Flotte TR et al. An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction. Gene Therapy 1995; 2: 29-37.
20. Tamayose K, Hirai Y, Shimada T. A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography. Hum Gene Ther 1996; 7: 507-513.
21. Yakobson B, Koch T, Winocour E. Replication of adeno-associated virus in synchronized cells without the addition of a helper virus. J Virol 1987; 61: 972-981.
22. Carter BJ, Laughlin CA, Maza LMdl, Myers M. Adeno-associated virus autointerference. Virology 1979; 92: 449-462.
23. Yang Q, Chen F, Trempe JP. Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins. J Virol 1994; 68: 4847-4856.
24. Winocour E, Callaham MF, Huberman E. Perturbation of the cell cycle by adeno-associated virus. Virology 1988; 167: 393-399.
25. Mendelson E, Smith MG, Miller IL, Carter BJ. Effect of a viral rep gene on transformation of cells by an adeno-associated virus vector. Virology 1988; 166: 612-615.
26. Labow MA, Graf LH Jr, Berns KI. Adeno-associated virus gene expression inhibits cellular transformation by heterologous genes. Mol Cell Biol 1987; 7: 1320-1325.
27. Khleif SN, Myers T, Carter BJ, Trempe JP. Inhibition of cellular transformation by the adeno-associated virus rep gene. Virology 1991; 181: 738-741.
28. Chang L-S, Shenk T. Adeno-associated virus P5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor. J Virol 1989; 63:3479-3488.
29. Tratschin JD, Miller IL, Smith MG, Carter BJ. Adeno-associated virus vector for high-frequency integration, expression, and rescue of genes in mammalian cells. Mol Cell Biol 1985; 5: 3251-3260.
30. Zhou SZ et al. Adeno-associated virus 2-mediated gene transfer in murine hematopoietic progenitor cells. Exp Hematol 1993; 21: 928-933.
31. Russell DW, Miller AD, Alexander IA. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc Natl Acad Sci USA 1994; 91: 8915-8919.
32. Podsakoff G, Wong KK Jr, Chatterjee S. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J Virol 1994; 68: 5656-5666.
33. Halbert CL, Alexander IE, Wolgamot GM, Miller AD. Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J Virol 1995; 69: 1473-1479.
34. Ferrari FK, Samulski T, Shenk T, Samulski RJ. Second-strand synthesis is a rate limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol 1996; 70: 3227-3234.
35. Fisher KJ et al. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J Virol 1996; 70: 520-532.
36. Alexander IE, Russell DW, Miller AD. DNA-damaging agents greatly increase the transduction of nondividing cells by adenoassociated virus vectors. J Virol 1994; 68: 8282-8287.
37. Russell DW, Alexander IA, Miller AD. DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc Natl Acad Sci USA 1995; 92: 5719-5723.
38. Graham FL, Prevec L. Manipulation of adenovirus vectors. Meth Mol Biol 1991; 7: 109-128.
39. Berns KI, Rose JA. Evidence for a single-stranded adenovirus-associated virus genome: isolation and separation of complementary single strands. J Virol 1970; 5: 693-699.
40. Carter BJ, Marcus-Sekura CJ, Laughlin CA, Ketner G. Properties of an adenovirus type 2 mutant, Ad2dl807, having a deletion near the right-hand genome terminus: failure to help AAV replication. Virology 1983; 126: 505-516.
41. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 1967; 26: 365-369.